Adjuvant denosumab in early breast-cancer

Paul de Boissieu¹, Thierry Trenque²

Affiliations

¹ Epidemiology and Public Health Department, Kremlin-Bicêtre University Hospital, 94270 Le Kremlin-Bicêtre, France. Electronic address: paul.de-boissieu@universite-paris-saclay.fr.
² Pharmacovigilance and Pharmacoepidemiology Department, Reims University Hospital, Reims, France.

PMID: 32135107
DOI: 10.1016/S1470-2045(20)30057-7

Comment

Adjuvant denosumab in early breast-cancer

Paul de Boissieu et al. Lancet Oncol. 2020 Mar.

. 2020 Mar;21(3):e123.

doi: 10.1016/S1470-2045(20)30057-7.

Authors

Paul de Boissieu¹, Thierry Trenque²

Affiliations

¹ Epidemiology and Public Health Department, Kremlin-Bicêtre University Hospital, 94270 Le Kremlin-Bicêtre, France. Electronic address: paul.de-boissieu@universite-paris-saclay.fr.
² Pharmacovigilance and Pharmacoepidemiology Department, Reims University Hospital, Reims, France.

PMID: 32135107
DOI: 10.1016/S1470-2045(20)30057-7

No abstract available

PubMed Disclaimer

Comment in

Adjuvant denosumab in early breast-cancer.
Fusco V, Campisi G, Bedogni A. Fusco V, et al. Lancet Oncol. 2020 Mar;21(3):e124. doi: 10.1016/S1470-2045(20)30066-8. Lancet Oncol. 2020. PMID: 32135108 No abstract available.
Adjuvant denosumab in early breast cancer - Authors' reply.
Coleman R, Zhou Y, Chan A; D-CARE investigators. Coleman R, et al. Lancet Oncol. 2020 Mar;21(3):e125. doi: 10.1016/S1470-2045(20)30099-1. Lancet Oncol. 2020. PMID: 32135109 No abstract available.

Comment on

Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial.
Coleman R, Finkelstein DM, Barrios C, Martin M, Iwata H, Hegg R, Glaspy J, Periañez AM, Tonkin K, Deleu I, Sohn J, Crown J, Delaloge S, Dai T, Zhou Y, Jandial D, Chan A. Coleman R, et al. Lancet Oncol. 2020 Jan;21(1):60-72. doi: 10.1016/S1470-2045(19)30687-4. Epub 2019 Dec 2. Lancet Oncol. 2020. PMID: 31806543 Clinical Trial.
Adjuvant denosumab in early breast cancer.
Peters N, Conroy M, O'Reilly S. Peters N, et al. Lancet Oncol. 2020 Mar;21(3):e121. doi: 10.1016/S1470-2045(20)30001-2. Lancet Oncol. 2020. PMID: 32135105 No abstract available.
Adjuvant denosumab in early breast cancer.
Scimeca M, Bonfiglio R, Urbano N, Schillaci O, Bonanno E. Scimeca M, et al. Lancet Oncol. 2020 Mar;21(3):e122. doi: 10.1016/S1470-2045(20)30019-X. Lancet Oncol. 2020. PMID: 32135106 No abstract available.

Cited by

Medication-Related Osteonecrosis of Jaws (MRONJ) Prevention and Diagnosis: Italian Consensus Update 2020.
Campisi G, Mauceri R, Bertoldo F, Bettini G, Biasotto M, Colella G, Consolo U, Di Fede O, Favia G, Fusco V, Gabriele M, Lo Casto A, Lo Muzio L, Marcianò A, Mascitti M, Meleti M, Mignogna MD, Oteri G, Panzarella V, Romeo U, Santarelli A, Vescovi P, Marchetti C, Bedogni A. Campisi G, et al. Int J Environ Res Public Health. 2020 Aug 18;17(16):5998. doi: 10.3390/ijerph17165998. Int J Environ Res Public Health. 2020. PMID: 32824826 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Adjuvant denosumab in early breast-cancer

Affiliations

Adjuvant denosumab in early breast-cancer

Authors

Affiliations

Comment in

Comment on

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources